Location · Farmington, CT
Clinical trials in Farmington, CT
23 recruiting studies have a site in Farmington, and 7 of them accept healthy volunteers.
23 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2/Phase 3
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Biohaven Therapeutics Ltd.
- Location
- Farmington, CT + 24 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Location
- Farmington, CT + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Location
- Farmington, CT + 56 other US sites
- Eligibility basics
- Ages 55–90
- RecruitingPhase 2
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Incyte Corporation
- Location
- Farmington, CT + 23 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Intra-Cellular Therapies, Inc.
- Location
- Farmington, CT + 19 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Janssen Research & Development, LLC
- Location
- Farmington, CT + 41 other US sites
- Eligibility basics
- Ages 18–74
- RecruitingPhase 2
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Intra-Cellular Therapies, Inc.
- Location
- Farmington, CT + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
Janssen Research & Development, LLC
- Location
- Farmington, CT + 14 other US sites
- Eligibility basics
- Ages 18–74
- RecruitingPhase 3
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Location
- Farmington, CT + 43 other US sites
- Eligibility basics
- Ages 55–90
- RecruitingPhase 3
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Novartis Pharmaceuticals
- Location
- Farmington, CT + 39 other US sites
- Eligibility basics
- Ages 21–70
- RecruitingPhase 2
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Cumberland Pharmaceuticals
- Location
- Farmington, CT + 17 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 2
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Syndeio Biosciences, Inc
- Location
- Farmington, CT + 20 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingPhase 3
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Neurocrine Biosciences
- Location
- Farmington, CT + 38 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
Priovant Therapeutics, Inc.
- Location
- Farmington, CT + 44 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Study of BHV-1400 in IgA Nephropathy
Biohaven Therapeutics Ltd.
- Location
- Farmington, CT + 13 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 1/Phase 2
A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)
Beam Therapeutics Inc.
- Location
- Farmington, CT + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Targeting Aging With a Ketone Ester for Function in Frailty
Buck Institute for Research on Aging
- Location
- Farmington, CT + 2 other US sites
- Eligibility basics
- Ages 65+
- RecruitingHealthy volunteers
Circulating Markers for Ischemic Heart Disease
UConn Health
- Location
- Farmington, CT
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Study of Circulating Monocytes in Patients With Ischemic Vascular Disease
UConn Health
- Location
- Farmington, CT
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 2
The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults
UConn Health
- Location
- Farmington, CT
- Eligibility basics
- Ages 65–80
- RecruitingHealthy volunteers
Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait
UConn Health
- Location
- Farmington, CT
- Eligibility basics
- Ages 50+ · Women only
- RecruitingHealthy volunteers
Effect of Force Magnitude on Canine Retraction and Gingival Crevicular Fluid Proteome
UConn Health
- Location
- Farmington, CT
- Eligibility basics
- Ages 11–16
- RecruitingHealthy volunteers
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
CHDI Foundation, Inc.
- Location
- Farmington, CT + 51 other US sites
- Eligibility basics
- Ages 18+